Capstone Investment Advisors
HRMY icon

Capstone Investment Advisors’s Harmony Biosciences HRMY Stock Holding History

Capstone Investment Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Sell
11,698
-17,363
-60% -$548K ﹤0.01% 1306
2026
Q1 		$814K Buy
29,061
+15,446
+113% +$506K ﹤0.01% 930
2025
Q4 		$509K Buy
13,615
+1,340
+11% +$44.1K ﹤0.01% 1142
2025
Q3 		$338K Buy
+12,275
New +$423K ﹤0.01% 1595

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capstone Investment Advisors's HRMY Position: Q2 2026 in Review

Capstone Investment Advisors reduced its Harmony Biosciences (HRMY) stake by 60% in Q2 2026, selling an estimated $548K and leaving 11,698 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Capstone Investment Advisors first reported a position in HRMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $814K in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Capstone Investment Advisors held 11,698 shares of Harmony Biosciences worth $426K as of Q2 2026.
  • Capstone Investment Advisors sold 17,363 Harmony Biosciences shares in Q2 2026, an estimated $548K.
  • Harmony Biosciences made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1306 holding.
  • Capstone Investment Advisors first reported a position in Harmony Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Capstone Investment Advisors's Harmony Biosciences position peaked at $814K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.